Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Total Debt / EBITDA

Albireo Pharma Inc Total Debt / EBITDA Chart (ALBO)

Albireo Pharma Inc annual/quarterly Total Debt / EBITDA from 2015 to 2020.
  • Albireo Pharma Inc Total Debt / EBITDA for the quarter ending June 06, 2020 was $0m a 69.44% decrease of 0m year over year
  • Albireo Pharma Inc Total Debt / EBITDA for the last 12 months ending June 06, 2020 was $0m a 58.97% decrease of 0m year over year
  • Albireo Pharma Inc Annual Total Debt / EBITDA for 2019 was $0m a -486.36% increase of 0m from 2018
  • Albireo Pharma Inc Annual Total Debt / EBITDA for 2016 was $0m a -239.29% increase of 1m from 2015
  • Albireo Pharma Inc Annual Total Debt / EBITDA for 2015 was $-2m a 34.22% decrease of -1m from 2014
Other Ratios Metrics:
  • Albireo Pharma Inc Total Debt / Capital for the quarter ending September 09, 2017 was $2m a -268.92% decrease of -6m year over year
  • Albireo Pharma Inc Other Liabilities for the quarter ending December 12, 2018 was $50m a 8.86% increase of 4m year over year
  • Albireo Pharma Inc Total Debt / Equity for the quarter ending September 09, 2017 was $2m a -291.29% decrease of -6m year over year
View Chart On Koyfin

Quarterly ALBO Total Debt / EBITDA Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
09/2017$0m
06/2017$0m
03/2017$0m
12/2016$0m

Annual ALBO Total Debt / EBITDA Data

2019$0m
2016$0m
2015$-2m
2014$-1m